Abbott Point of Care (APOC) has identified that the i-STAT kaolin act test may be prolonged immediately after the administration of an initial full dose aprotinin bolus of 400 kallikrein inhibitor units (kiu)/ml. Once the drug has fully distributed throughout the body there is no impact on the act result reported.